From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA approves marketing for diabetic foot ulcers shock wave therapy

from MD Magazine

From Jan. 3: The U.S. Food and Drug Administration has approved marketing for the Dermapace System, the first device designed to treat diabetic foot ulcers with shock wave technology. The device, from Sanuwave Health, was previously approved outside of the U.S. for advanced wound care indications, according to the manufacturing company. Its FDA indication is for the treatment of chronic, full-thickness diabetic foot ulcers, with wound areas measuring no larger than 16 cm2, but without bone exposure. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063